Comparison of event‐free survival in patients with PDC <80% who received fixed‐dose vs free combinations of RAS inhibitor and thiazide diuretic. A, major adverse cardiac events; B, hospitalization for heart failure; C, new diagnosis of chronic kidney disease; D, initiation of dialysis. PDC, proportion of days covered; RAS, renin‐angiotensin system